Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Regular Growth
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Regular Growth

Add To Compare

30.957 (-0.489%)
NAV on October 24, 2025
Category Equity:
Sector - Healthcare
Total Assets 1,296 cr
Turnover Ratio 11.18%
Expense Ratio 2.11%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: 0.91%
  • 1Y: 1.94%
  • 3M: 0.05%
  • 3Y: 22.78%
  • 6M: 3.96%
  • 5Y: 18.08%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since about 1 year)
ISIN INF277K016A9
Fund Family Tata
P/E Ratio 39.89
P/B Ratio 6.32
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
CREDIT QUALITY (%)
AAA -
AA -
A -
BBB -
BB -
B -
Below B -
Unrated -
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 2.82
Beta 0.94
R-Squared 96.41
Info Ratio 0.78
Tracking Err 3.23
Sortino 1.597
Sharpe 0.903
Std Dev 16.047
Risk -
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

View Factsheet
-
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Sbi
SBI Healthcare Opportunities Fund Direct Growth
502.802 8.19% 3,933 cr 0.91% -
Icici
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
43.650 7.06% 6,227 cr 1.03% -
Uti
UTI Healthcare Fund-Growth Option- Direct
329.607 5.53% 1,097 cr 1.3% -


Other plans of Tata India Pharma & Healthcare

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund